Tag: Pharmather - Page 7 - Psychedelic Alpha

Read more about the article PharmaTher Announces Application for OTCQB Listing

PharmaTher Announces Application for OTCQB Listing

Post published:December 30, 2020
Post category:Press Release

Read more about the article PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics

Post published:December 21, 2020
Post category:Press Release

Read more about the article PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders

PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders

Post published:December 15, 2020
Post category:Press Release

Read more about the article PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease

PharmaTher Granted Pre-IND Meeting with the FDA for Ketamine in Parkinson’s Disease

Post published:December 10, 2020
Post category:Press Release

Read more about the article PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease

PharmaTher Files FDA Pre-IND Meeting Request for Ketamine in Parkinson’s Disease

Post published:December 9, 2020
Post category:Press Release

Read more about the article PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform

PharmaTher Expands Research Partnership with University Health Network For Development of Digital Therapeutics Platform

Post published:December 1, 2020
Post category:Press Release

Read more about the article PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs

PharmaTher Provides Update on its Psychedelic Pharmaceuticals Programs

Post published:November 24, 2020
Post category:Press Release

Read more about the article PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform

PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform

Post published:November 18, 2020
Post category:Press Release

Read more about the article PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer

Post published:November 16, 2020
Post category:Press Release

Read more about the article Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor

Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor

Post published:November 11, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.